116 related articles for article (PubMed ID: 2833400)
41. Effect on prognosis of bone marrow infiltration detected by magnetic resonance imaging in small cell lung cancer.
Seto T; Imamura F; Kuriyama K; Funakoshi T; Gotoh H; Nakayama T; Nakamura S; Horai T
Eur J Cancer; 1997 Dec; 33(14):2333-7. PubMed ID: 9616277
[TBL] [Abstract][Full Text] [Related]
42. Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
Krug LM; Milton DT; Jungbluth AA; Chen LC; Quaia E; Pandit-Taskar N; Nagel A; Jones J; Kris MG; Finn R; Smith-Jones P; Scott AM; Old L; Divgi C
J Thorac Oncol; 2007 Oct; 2(10):947-52. PubMed ID: 17909358
[TBL] [Abstract][Full Text] [Related]
43. [Value of bone marrow trephine biopsy in evaluating the extent of small cell lung cancer].
Zych J; Polowiec Z; Wiatr E; Broniek A; Grymiński J; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 1993; 61(9-10):474-80. PubMed ID: 8111323
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis and staging in small cell lung cancer.
Klastersky J
Curr Opin Oncol; 1990 Apr; 2(2):331-3. PubMed ID: 1965629
[No Abstract] [Full Text] [Related]
45. Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma.
Layer G; Steudel A; Schüller H; van Kaick G; Grünwald F; Reiser M; Schild HH
Cancer; 1999 Feb; 85(4):1004-9. PubMed ID: 10091781
[TBL] [Abstract][Full Text] [Related]
46. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
Vredenburgh JJ; Ball ED
Cancer Res; 1990 Nov; 50(22):7216-20. PubMed ID: 2171759
[TBL] [Abstract][Full Text] [Related]
47. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
[TBL] [Abstract][Full Text] [Related]
48. Radionuclide imaging of bone marrow metastases with a Tc-99m labeled monoclonal antibody to small cell lung carcinoma.
Balaban EP; Walker BS; Cox JV; Sein AA; Abrams PG; Salk D; Sheehan RG; Frenkel EP
Clin Nucl Med; 1991 Oct; 16(10):732-6. PubMed ID: 1660386
[TBL] [Abstract][Full Text] [Related]
49. Bone marrow involvement in anaplastic small cell lung cancer. Diagnosis, hematologic features, and prognostic implications.
Bezwoda WR; Lewis D; Livini N
Cancer; 1986 Oct; 58(8):1762-5. PubMed ID: 3019512
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables.
Tritz DB; Doll DC; Ringenberg QS; Anderson S; Madsen R; Perry MC; Yarbro JW
Cancer; 1989 Feb; 63(4):763-6. PubMed ID: 2536586
[TBL] [Abstract][Full Text] [Related]
51. How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer?
Perrin-Resche I; Bizais Y; Buhe T; Fiche M
Eur J Nucl Med; 1993 May; 20(5):420-5. PubMed ID: 8390936
[TBL] [Abstract][Full Text] [Related]
52. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
[TBL] [Abstract][Full Text] [Related]
53. Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas.
Stahel RA; Speak JA; Bernal SD
Int J Cancer; 1985 Jan; 35(1):11-7. PubMed ID: 2578439
[TBL] [Abstract][Full Text] [Related]
54. Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline.
Weber E; Lehmann HP; Beck-Sickinger AG; Wawrzynczak EJ; Waibel R; Folkers G; Stahel RA
Clin Exp Immunol; 1993 Aug; 93(2):279-85. PubMed ID: 7688677
[TBL] [Abstract][Full Text] [Related]
55. [Clinical and biological aspects of intensive chemotherapy with autologous bone marrow grafts in small-cell bronchial cancer].
Symann M; Humblet Y; Bosly A
Bull Mem Acad R Med Belg; 1989; 144(3-4):213-21; discussion 222-3. PubMed ID: 2553180
[TBL] [Abstract][Full Text] [Related]
56. Novel antigens characteristic of neuroendocrine malignancies.
Broers JL; Mijnheere EP; Rot MK; Schaart G; Sijlmans A; Boerman OC; Ramaekers FC
Cancer; 1991 Feb; 67(3):619-33. PubMed ID: 1845952
[TBL] [Abstract][Full Text] [Related]
57. Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin.
Roy DC; Ouellet S; Le Houillier C; Ariniello PD; Perreault C; Lambert JM
J Natl Cancer Inst; 1996 Aug; 88(16):1136-45. PubMed ID: 8757193
[TBL] [Abstract][Full Text] [Related]
58. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
[TBL] [Abstract][Full Text] [Related]
59. Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1.
Pasini F; Pelosi G; Ledermann JA; Cetto GL
Int J Cancer Suppl; 1994; 8():53-6. PubMed ID: 8194897
[TBL] [Abstract][Full Text] [Related]
60. Artifactual distortion of cells simulating metastatic small cell carcinoma in the bone marrow.
Cartagena N; Suster S; Cabello-Inchausti B
Ann Clin Lab Sci; 1993; 23(2):130-6. PubMed ID: 8384430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
